JP2023526157A5 - - Google Patents

Info

Publication number
JP2023526157A5
JP2023526157A5 JP2022556460A JP2022556460A JP2023526157A5 JP 2023526157 A5 JP2023526157 A5 JP 2023526157A5 JP 2022556460 A JP2022556460 A JP 2022556460A JP 2022556460 A JP2022556460 A JP 2022556460A JP 2023526157 A5 JP2023526157 A5 JP 2023526157A5
Authority
JP
Japan
Prior art keywords
hla
expression profile
cells
gene expression
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556460A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526157A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/023225 external-priority patent/WO2021188941A1/en
Publication of JP2023526157A publication Critical patent/JP2023526157A/ja
Publication of JP2023526157A5 publication Critical patent/JP2023526157A5/ja
Pending legal-status Critical Current

Links

JP2022556460A 2020-03-20 2021-03-19 単一細胞解析により末梢血からt細胞及びt細胞レセプターを免疫治療のために単離する方法 Pending JP2023526157A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062992715P 2020-03-20 2020-03-20
US62/992,715 2020-03-20
PCT/US2021/023225 WO2021188941A1 (en) 2020-03-20 2021-03-19 Methods of isolating t cells and t-cell receptors from peripheral blood by single-cell analysis for immunotherapy

Publications (2)

Publication Number Publication Date
JP2023526157A JP2023526157A (ja) 2023-06-21
JP2023526157A5 true JP2023526157A5 (https=) 2024-04-03

Family

ID=75478263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556460A Pending JP2023526157A (ja) 2020-03-20 2021-03-19 単一細胞解析により末梢血からt細胞及びt細胞レセプターを免疫治療のために単離する方法

Country Status (9)

Country Link
US (1) US20230183802A1 (https=)
EP (1) EP4121513A1 (https=)
JP (1) JP2023526157A (https=)
KR (1) KR20220161361A (https=)
CN (1) CN115485368A (https=)
AU (1) AU2021239379A1 (https=)
CA (1) CA3171583A1 (https=)
IL (1) IL296608A (https=)
WO (1) WO2021188941A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4594751A1 (en) 2022-09-27 2025-08-06 UCL Business Ltd Detecting cancer
GB202302709D0 (en) * 2023-02-24 2023-04-12 Genome Res Ltd Method of identifying t cell recpetors of interest
WO2024197072A2 (en) * 2023-03-21 2024-09-26 Alaunos Therapeutics, Inc. Identification of neoantigen-reactive t cell receptors
EP4603598A1 (en) * 2024-02-13 2025-08-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Identification of reactive t cells
CN121208363B (zh) * 2025-11-26 2026-03-17 中国人民解放军总医院第一医学中心 IgA肾病的致病T细胞亚群的鉴定用试剂盒及鉴定系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034334B2 (en) 2002-09-06 2011-10-11 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
US20120244133A1 (en) 2011-03-22 2012-09-27 The United States of America, as represented by the Secretary, Department of Health and Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
EP3628322A1 (en) * 2013-03-01 2020-04-01 The United States of America, as represented by the Secretary, Department of Health and Human Services Cd8+ t cells that also express pd-1 and/or tim-3 for the treatment of cancer
JP6599450B2 (ja) 2014-10-02 2019-10-30 アメリカ合衆国 がん特異的突然変異に対し抗原特異性を有するt細胞を単離する方法
AU2014407539B2 (en) 2014-10-02 2020-10-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of isolating T cell receptors having antigenic specificity for a cancer-specific mutation
EP3234130B1 (en) * 2014-12-19 2020-11-25 The Broad Institute, Inc. Methods for profiling the t-cell- receptor repertoire
WO2016179006A1 (en) * 2015-05-01 2016-11-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of isolating t cells and t cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
WO2017048614A1 (en) 2015-09-15 2017-03-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of isolating tumor-reactive t cell receptors from tumor or peripheral blood
CN110612446B (zh) 2017-03-31 2023-07-04 美国卫生和人力服务部 分离新抗原-特异性t细胞受体序列的方法
US20210263012A1 (en) * 2017-11-17 2021-08-26 The Broad Institute, Inc. Methods and compositions for modulating immune responses and lymphocyte activity
WO2019112932A1 (en) * 2017-12-04 2019-06-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of enriching cell populations for cancer-specific t cells using in vitro stimulation of memory t cells
US20220033774A1 (en) * 2018-04-16 2022-02-03 The Regents Of The University Of California Compositions and methods for cytotoxic cd4+ t cells

Similar Documents

Publication Publication Date Title
JP2023526157A5 (https=)
US20230381231A1 (en) Compositions for cancer treatment and methods and uses for cancer treatment and prognosis
US12421557B2 (en) Methods for predicting outcomes and treating colorectal cancer using a cell atlas
US20240264151A1 (en) Methods and Compositions for Treating Diseases Associated with Exhausted T Cells
Venema et al. Single-cell RNA sequencing of blood and ileal T cells from patients with crohn's disease reveals tissue-specific characteristics and drug targets
US12227578B2 (en) Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action
US6905827B2 (en) Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) Methods and compositions for diagnosing and monitoring transplant rejection
CN114616467B (zh) 筛选原代人类细胞中的同源t细胞和表位反应性的高通量方法
US7026121B1 (en) Methods and compositions for diagnosing and monitoring transplant rejection
US11249081B2 (en) Methods for the identification, targeting and isolation of human dendritic cell (DC) precursors “pre-DC” and their uses thereof
CA2895133A1 (en) Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis
US11630103B2 (en) Product and methods useful for modulating and evaluating immune responses
AU2010326066A1 (en) Classification of cancers
US12584844B2 (en) Flow cytometry immunoprofiling of peripheral blood
US20210293820A1 (en) Methods of activating dysfunctional immune cells and treatment of cancer
Browne et al. An analytically and diagnostically sensitive RNA extraction and RT-qPCR protocol for peripheral blood mononuclear cells
CN109777872A (zh) 肺癌中的t细胞亚群及其特征基因
US20230183802A1 (en) Methods of isolating t cells and t-cell receptors from peripheral blood by single-cell analysis for immunotherapy
US20240254565A1 (en) Unique cancer associated fibroblast subsets predict response to immunotherapy
US20240091259A1 (en) Generation of anti-tumor t cells
WO2024003360A1 (en) Biomarkers and uses thereof for the treatment of neuroblastoma
US20240108689A1 (en) Modulation of a pathogenic phenotype in th1 cells
US20220326216A1 (en) T cell gene expression analysis for use in t cell therapies
KR20260030761A (ko) 산전 검사를 위한 방법 및 조성물